Home
>
US Stocks
>
Nemaura Medical Inc
Nemaura Medical Inc
NMRD

Nemaura Medical Inc

$5.8413.48%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
5.73
Today Low/High
5.73 / 5.84
52 Week Low/High
$3.12 / $17.4
Market Cap
$152.2M

Company Details

Nemaura Medical Inc. (NMRD) is a medical technology company developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT™, and proBEAT™. sugarBEAT®, a CE mark approved Class IIb medical device, is a non-invasive and flexible continuous glucose monitor (CGM) providing actionable insights derived from real time glucose measurements and daily glucose trend data, which may help people with diabetes and pre-diabetes to better manage, reverse and prevent the onset of diabetes. Nemaura is planning to submit a PMA application for sugarBEAT® during the second quarter of 2020 for FDA review of this device under medical device regulations. proBEAT™ comprises a non-invasive glucose monitor and a digital healthcare subscription service and is due to be launched in the US as a general wellness product.
Organisation
Nemaura Medical Inc
Headquaters
New York, New York, US
Employees
25
Industry
Health Technology
CEO
Dewan Chowdhury

Discover more

Frequently Asked Questions

What is Nemaura Medical Inc share price today

Can Indians buy Nemaura Medical Inc shares?

How can I buy Nemaura Medical Inc shares from India?

Can Fractional shares of Nemaura Medical Inc be purchased?

What are the documents required to start investing in Nemaura Medical Inc stocks?

We are a SEBI registered investement advisor